Twist Bioscience Corporation (TWST) /
The revenue of Twist Bioscience Corporation over the past 9 years
Chart Twist Bioscience Corporation: revenue, fiscal 2017–2025 Open the chart →Twist Bioscience Corporation reported revenue of $376.57M in fiscal 2025, the latest fiscal year on file. In fiscal 2017 it was $10.77M — up 3397% over 8 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2018: up 136%, from $10.77M to $25.43M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Sep 30, 2025 | $376.57M |
| 2024ended Sep 30, 2024 | $312.97M |
| 2023ended Sep 30, 2023 | $245.11M |
| 2022ended Sep 30, 2022 | $203.56M |
| 2021ended Sep 30, 2021 | $132.33M |
| 2020ended Sep 30, 2020 | $90.1M |
| 2019ended Sep 30, 2019 | $54.38M |
| 2018ended Sep 30, 2018 | $25.43M |
| 2017ended Sep 30, 2017 | $10.77M |
Fiscal years as Twist Bioscience Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Twist Bioscience Corporation
- The profitability of Twist Bioscience Corporation
- The cash flow of Twist Bioscience Corporation
- The debt of Twist Bioscience Corporation
- All of Twist Bioscience Corporation's financials, charted
Companies of a similar size
- HQYHEALTHEQUITY, INC.
- PCVXVaxcyte, Inc.
- FLSFLOWSERVE CORP
- ZETAZeta Global Holdings Corp.
- BRKRBRUKER CORPORATION
Not investment advice. This page shows what Twist Bioscience Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.